Company: AEMD
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001683168-25-006049
Chunk: 4

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-13
Form: 10-Q
Item: Item 1
Chunk 4
---
–  
     (2,571,440) 
     –  
     (2,571,440)
  
    Other comprehensive loss 
     –  
     –  
     –  
     –  
     (833) 
     (833)
  
    BALANCE – JUNE 30, 2024 
     1,742,180  
    $1,743  
    $165,856,814  
    $(157,138,168) 
    $(7,773) 
    $8,712,616 

The accompanying notes are an integral part of these
condensed consolidated financial statements.

 6 

AETHLON MEDICAL, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Three Months Ended June 30, 2025 and 2024

(Unaudited)

    Three months  Ended  June 30, 2025  
    Three months  Ended  June 30, 2024 

    Cash flows used in operating activities: 

    Net loss 
    $(1,761,858) 
    $(2,571,440)
  
    Adjustments to reconcile net loss to net cash used in operating activities: 

    Depreciation and amortization 
     82,637  
     86,060 
  
    Stock based compensation 
     72,442  
     139,328 
  
    Accretion of right-of-use operating lease asset 
     72,270  
     (1,217)
  
    Changes in operating assets and liabilities: 

    Prepaid expenses and other current assets 
     164,031  
     89,872 
  
    Accounts payable and other current liabilities 
     (137,492) 
     323,776 
  
    Deferred revenue 
     –  
     – 
  
    Due to related parties 
     (206,967) 
     186,084 
  
    Net cash used in operating activities 
     (1,714,937) 
     (1,747,537)

    Cash flows (used in) provided by financing activities: 

    Proceeds from the issuance of common stock, net 
     –  
     3,539,907 
  
    Proceeds from the issuance of common